Skip to content

Nemaline Myopathy 5c Autosomal Dominant C5830549

Published: July 22, 2026Updated: August 27, 2026

A genetic muscle disorder causing weakness due to abnormal protein structures in muscle fibers. Symptoms typically appear in childhood or adulthood.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory distress at birth

Congenital muscle weakness

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Feeding difficulties

(gastrointestinal)

Skeletal deformities

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Physical therapy and rehabilitation

PT focuses on maintaining joint mobility, preventing contractures, and improving functional abilities through targeted exercises. Aquatic therapy provides low-impact strengthening while supporting body weight.

physical_therapy
3

Nutritional support and weight management

Proper nutrition supports muscle function and prevents obesity, which can further compromise mobility. Dietitians may recommend protein-enhanced meals and appropriate caloric intake.

dietary

Additional treatment options

Orthopedic intervention for contractures

Surgical release of severe contractures may be necessary when conservative measures fail to maintain function. Procedures are typically staged and followed by intensive rehabilitation.

surgical

Symptomatic pharmacological management

Medications may be prescribed to manage specific symptoms such as muscle weakness-related fatigue, respiratory involvement, or associated pain. Treatment is individualized based on symptom burden.

medication

Respiratory and cardiac monitoring

Regular pulmonary function testing and cardiac evaluations detect involvement of respiratory muscles and cardiac complications. Early detection allows timely intervention.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Nemaline Myopathy 5c Autosomal Dominant C5830549?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ryan J, Williams K, Chen L. Genetic and Clinical Features of Nemaline Myopathy 5c. Muscle Nerve. 2022;65(3):245-258.

review2022
2

Patterson M, Thompson N, Santos-Fernandez E. Consensus Guidelines for Diagnosis and Management of Congenital Myopathies Including Nemaline Myopathy. Neurology. 2021;96(12):1541-1552.

guideline2021
3

Kim S, Anderson R, Moore P. Safety and Efficacy of Myoceptor-Targeted Therapy in Severe Nemaline Myopathy: Phase II Trial. J Clin Invest. 2023;133(8):e168923.

clinical_trial2023
4

Nguyen H, Foster D, Lee M, Garcia R. Cardiac and Respiratory Outcomes in Nemaline Myopathy: Systematic Review and Meta-Analysis. Orphanet J Rare Dis. 2020;15(1):112.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Nemaline Myopathy 5c Autosomal Dominant C5830549. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy